$544.49
6.431.2%
Last update: Nov 10, 4:00 PM
Chemed Corp
CHENYSE
Chemed rose 20.8% from $445.53 to $538.06, ahead of the S&P 500's +9.8%. Its worst day was Feb 26 (−15.0%), and its low came Mar 27 at $368.59.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $6.42 missed the $6.85 estimate on $639.3M revenue (est. $657.9M); FY EPS guidance of $23.25–$24.25 against the $23.42 consensus.
−15.0%, the year's worst day, on 822K shares, the year's heaviest volume · S&P 500 −0.6%
Story events cover the past 12 months · Times ET
Chemed closed at its lowest level of the year, 17.3% below where the year started.
−0.9% · S&P 500 −1.7%
EPS of $5.65 beat the $5.21 estimate on $657.5M revenue (est. $648.0M); FY EPS guidance of $24.00–$24.75 against the $23.48 consensus.
+10.0%, the year's best day · S&P 500 +0.8%
EPS of $6.06 beat the $5.50 estimate on $673.3M revenue (est. $664.2M); FY EPS guidance of $25.00–$25.75 against the $24.01 consensus.
+4.2% · S&P 500 −1.5%
Chemed closed at its highest level of the year, 24.1% above where the year started.
+0.6% · S&P 500 +0.6%
Chemed shares fell 5.2%, while the S&P 500 rose 0.7%.
−5.2% · S&P 500 +0.7%
EPS of $6.75 beat the $6.33 estimate on $690.9M revenue (est. $684.0M); FY EPS guidance of $25.75 against the $25.11 consensus.
+4.8% · S&P 500 +0.3%
Where it ended: a close of $538.06 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $7.27, revenue est. $711.6M).
As of the Nov 9, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CHE and SPY from Benzinga historical bars. Not investment advice.
